India · Delayed Price · Currency is INR Neogen Chemicals Statistics
Total Valuation
NSE:NEOGEN has a market cap or net worth of INR 67.27 billion. The enterprise value is 81.17 billion.
| Market Cap | 67.27B |
| Enterprise Value | 81.17B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Aug 13, 2026 |
Share Statistics
NSE:NEOGEN has 30.04 million shares outstanding. The number of shares has increased by 0.74% in one year.
| Current Share Class | 30.04M |
| Shares Outstanding | 30.04M |
| Shares Change (YoY) | +0.74% |
| Shares Change (QoQ) | +3.17% |
| Owned by Insiders (%) | 30.87% |
| Owned by Institutions (%) | 19.71% |
| Float | 13.64M |
Valuation Ratios
The trailing PE ratio is 166.15 and the forward PE ratio is 77.86. NSE:NEOGEN's PEG ratio is 1.26.
| PE Ratio | 166.15 |
| Forward PE | 77.86 |
| PS Ratio | 7.27 |
| PB Ratio | 8.24 |
| P/TBV Ratio | 8.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.26 |
Enterprise Valuation
| EV / Earnings | 228.01 |
| EV / Sales | 8.77 |
| EV / EBITDA | 52.81 |
| EV / EBIT | 65.20 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 1.71.
| Current Ratio | 1.17 |
| Quick Ratio | 0.55 |
| Debt / Equity | 1.71 |
| Debt / EBITDA | 9.10 |
| Debt / FCF | n/a |
| Interest Coverage | 1.49 |
Financial Efficiency
Return on equity (ROE) is 3.58% and return on invested capital (ROIC) is 4.00%.
| Return on Equity (ROE) | 3.58% |
| Return on Assets (ROA) | 2.95% |
| Return on Invested Capital (ROIC) | 4.00% |
| Return on Capital Employed (ROCE) | 6.40% |
| Weighted Average Cost of Capital (WACC) | 7.59% |
| Revenue Per Employee | 13.61M |
| Profits Per Employee | 523,529 |
| Employee Count | 680 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.09 |
Taxes
In the past 12 months, NSE:NEOGEN has paid 144.70 million in taxes.
| Income Tax | 144.70M |
| Effective Tax Rate | 28.90% |
Stock Price Statistics
The stock price has increased by +47.51% in the last 52 weeks. The beta is 0.73, so NSE:NEOGEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +47.51% |
| 50-Day Moving Average | 2,316.57 |
| 200-Day Moving Average | 1,784.60 |
| Relative Strength Index (RSI) | 41.09 |
| Average Volume (20 Days) | 203,483 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEOGEN had revenue of INR 9.26 billion and earned 356.00 million in profits. Earnings per share was 13.39.
| Revenue | 9.26B |
| Gross Profit | 4.27B |
| Operating Income | 1.24B |
| Pretax Income | 500.70M |
| Net Income | 356.00M |
| EBITDA | 1.53B |
| EBIT | 1.24B |
| Earnings Per Share (EPS) | 13.39 |
Balance Sheet
The company has 49.50 million in cash and 13.95 billion in debt, with a net cash position of -13.90 billion or -462.73 per share.
| Cash & Cash Equivalents | 49.50M |
| Total Debt | 13.95B |
| Net Cash | -13.90B |
| Net Cash Per Share | -462.73 |
| Equity (Book Value) | 8.16B |
| Book Value Per Share | 309.59 |
| Working Capital | 2.05B |
Cash Flow
In the last 12 months, operating cash flow was -2.31 billion and capital expenditures -5.56 billion, giving a free cash flow of -7.87 billion.
| Operating Cash Flow | -2.31B |
| Capital Expenditures | -5.56B |
| Depreciation & Amortization | 291.98M |
| Net Borrowing | 7.54B |
| Free Cash Flow | -7.87B |
| FCF Per Share | -262.03 |
Margins
Gross margin is 46.14%, with operating and profit margins of 13.41% and 3.85%.
| Gross Margin | 46.14% |
| Operating Margin | 13.41% |
| Pretax Margin | 5.41% |
| Profit Margin | 3.85% |
| EBITDA Margin | 16.56% |
| EBIT Margin | 13.41% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.04%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.47% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.74% |
| Shareholder Yield | -0.69% |
| Earnings Yield | 0.60% |
| FCF Yield | -11.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:NEOGEN is 2,212.20, which is -0.58% lower than the current price. The consensus rating is "Buy".
| Price Target | 2,212.20 |
| Price Target Difference | -0.58% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 49.44% |
| EPS Growth Forecast (3Y) | 58.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |